Nominated as “Norway’s smartest industrial company”

Thermo Fisher Scientific is one of three finalists to win the award and title in Oslo this Tuesday. The technology which the biotech company is nominated for, is development of faster and cheaper DNA-sequencing. More than 70 companies were candidates for this year’s price, according to the Norwegian online tech magazine Teknisk Ukeblad.  Thermo Fisher Scientific is one […]

Ny rapport om helsenæringens verdi

En ny rapport om helsenæringens verdi er ute. Du kan laste ned rapporten her.     Oslo Cancer Cluster er del av et konsortium som ønsker en oversikt over helsenæringens tilstand i Norge. Helseindustrien er en ung næring i Norge. Derfor måles den ikke som andre næringer av Statistisk Sentralbyrå. Dette er grunnen til at konsortiet har […]

OncoImmunity AS wins the EU SME Instrument grant

The bioinformatics company OncoImmunity AS was ranked fourth out of 250 applicants for this prestigious grant. 250 companies submitted proposals to the same topic call as OncoImmunity AS. Only six projects were funded. “We applied for the SME instrument grant as it represents an ideal vehicle for funding groundbreaking and innovative projects with a strong […]

Vaccibody moves forward with HPV-study

Oslo Cancer Cluster member Vaccibody is moving forward with the first vaccination of a patient with the human papillomavirus, HPV-virus, in a phase IIa study using the company´s immunotherapy platform.  The primary objectives of the phase IIa study are to assess T cell mediated immune responses in the peripheral blood and to evaluate early signs […]